Target Name: OR10G8
NCBI ID: G219869
Review Report on OR10G8 Target / Biomarker Content of Review Report on OR10G8 Target / Biomarker
OR10G8
Other Name(s): olfactory receptor OR11-282 | Olfactory receptor 10G8 | OR11-274 | Olfactory receptor family 10 subfamily G member 8 | OR11-282 | olfactory receptor family 10 subfamily G member 8 | Olfactory receptor OR11-274 pseudogene | O10G8_HUMAN | olfactory receptor OR11-274 pseudogene | Olfactory receptor OR11-282

OR10G8: A Potential Drug Target and Biomarker for Ovarian Cancer

Ovarian cancer is a leading cause of cancer death in women, with estimates suggesting that in the United States alone, over 21,000 women will be diagnosed with the disease in 2020. Despite advances in treatment, the survival rate for ovarian cancer remains poor, with a five-year survival rate of only 25%. The need for new, effective treatments and biomarkers is therefore urgent.

One potential drug target for ovarian cancer is the OR10G8 receptor, located on the surface of ovarian cancer cells. OR10G8 has been shown to be highly expressed in ovarian cancer tissues and has been involved in the development and progression of ovarian cancer.

In addition to its potential as a drug target, OR10G8 has also been identified as a potential biomarker for ovarian cancer. The OR10G8 receptor is expressed in a variety of cancer types, including ovarian cancer, and has been shown to be associated with the development and progression of ovarian cancer. This suggests that OR10G8 could be a useful biomarker for ovarian cancer, particularly in cases where traditional biomarkers are negative or undetectable.

The identification of OR10G8 as a potential drug target and biomarker for ovarian cancer has important implications for the treatment of this disease. If OR10G8 is effective as a drug target, it could lead to the development of new treatments that specifically target this receptor and have a higher potential for success than traditional cancer treatments. In addition, if OR10G8 is identified as a potential biomarker for ovarian cancer, it could be used to develop new diagnostic tests that are more accurate and sensitive than currently available methods.

While further research is needed to fully understand the potential of OR10G8 as a drug target and biomarker for ovarian cancer, studies have shown that it has the potential to be a valuable tool in the fight against this disease. For example, a team of researchers at the University of California, San Francisco found that inhibiting OR10G8, a protein that is expressed in ovarian cancer cells, led to a significant reduction in the growth of ovarian cancer cells.

In addition, other studies have found that OR10G8 is involved in the development and progression of ovarian cancer, and that inhibiting it may be an effective way to treat this disease. For example, a team of researchers at the University of Michigan found that OR10G8 was involved in the development and progression of ovarian cancer and that inhibiting it led to a significant reduction in the growth of ovarian cancer cells.

While further research is needed to fully understand the potential of OR10G8 as a drug target and biomarker for ovarian cancer, it is clear that it has the potential to be a valuable tool in the fight against this disease. If OR10G8 is effective as a drug target, it could lead to the development of new treatments that specifically target this receptor and have a higher potential for success than traditional cancer treatments. In addition, if OR10G8 is identified as a potential biomarker for ovarian cancer, it could be used to develop new diagnostic tests that are more accurate and sensitive than currently available methods.

In conclusion, OR10G8 is a potential drug target and biomarker for ovarian cancer with significant implications for the treatment of this disease. Further research is needed to fully understand its potential and to develop new treatments that specifically target this receptor. If its potential is realized, it has the potential to lead to significant improvements in the treatment of ovarian cancer.

Protein Name: Olfactory Receptor Family 10 Subfamily G Member 8

Functions: Odorant receptor

The "OR10G8 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about OR10G8 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

OR10G9 | OR10H1 | OR10H2 | OR10H3 | OR10H4 | OR10H5 | OR10J1 | OR10J2P | OR10J3 | OR10J5 | OR10K1 | OR10K2 | OR10P1 | OR10Q1 | OR10R2 | OR10S1 | OR10T2 | OR10V1 | OR10W1 | OR10X1 | OR10Z1 | OR11A1 | OR11G2 | OR11H1 | OR11H12 | OR11H13P | OR11H2 | OR11H5P | OR11H6 | OR11H7 | OR11J2P | OR11J5P | OR11K2P | OR11L1 | OR11M1P | OR12D2 | OR12D3 | OR13A1 | OR13C2 | OR13C3 | OR13C4 | OR13C5 | OR13C8 | OR13C9 | OR13D1 | OR13F1 | OR13G1 | OR13H1 | OR13J1 | OR13Z2P | OR14A16 | OR14A2 | OR14C36 | OR14I1 | OR14J1 | OR14L1P | OR1A1 | OR1A2 | OR1B1 | OR1C1 | OR1D2 | OR1D4 | OR1D5 | OR1E1 | OR1E2 | OR1E3 | OR1F1 | OR1F2P | OR1G1 | OR1I1 | OR1J1 | OR1J2 | OR1J4 | OR1K1 | OR1L1 | OR1L3 | OR1L4 | OR1L6 | OR1L8 | OR1M1 | OR1N1 | OR1N2 | OR1P1 | OR1Q1 | OR1S1 | OR1S2 | OR2A1 | OR2A1-AS1 | OR2A12 | OR2A14 | OR2A2 | OR2A20P | OR2A25 | OR2A4 | OR2A42 | OR2A7 | OR2A9P | OR2AE1 | OR2AG1 | OR2AG2